167 related articles for article (PubMed ID: 35021009)
1. Targeted Profiling of Epitranscriptomic Reader, Writer, and Eraser Proteins Accompanied with Radioresistance in Breast Cancer Cells.
Qi TF; Miao W; Wang Y
Anal Chem; 2022 Jan; 94(3):1525-1530. PubMed ID: 35021009
[TBL] [Abstract][Full Text] [Related]
2. Targeted Quantitative Profiling of Epitranscriptomic Reader, Writer, and Eraser Proteins Using Stable Isotope-Labeled Peptides.
Qi TF; Liu X; Tang F; Yin J; Yu K; Wang Y
Anal Chem; 2022 Sep; 94(37):12559-12564. PubMed ID: 36084281
[No Abstract] [Full Text] [Related]
3. Parallel-reaction monitoring revealed altered expression of a number of epitranscriptomic reader, writer, and eraser proteins accompanied with colorectal cancer metastasis.
Qi TF; Tang F; Yin J; Miao W; Wang Y
Proteomics; 2023 Feb; 23(3-4):e2200059. PubMed ID: 35443089
[TBL] [Abstract][Full Text] [Related]
4. Targeted Profiling of Epitranscriptomic Reader, Writer, and Eraser Proteins Regulated by H3K36me3.
Yin J; Qi TF; Li L; Wang Y
Anal Chem; 2023 Jun; 95(25):9672-9679. PubMed ID: 37296074
[TBL] [Abstract][Full Text] [Related]
5. Targeted Proteomic Analysis Revealed Kinome Reprogramming during Acquisition of Radioresistance in Breast Cancer Cells.
Miao W; Bade D; Wang Y
J Proteome Res; 2021 May; 20(5):2830-2838. PubMed ID: 33739118
[TBL] [Abstract][Full Text] [Related]
6. Temporal Profiling of Epitranscriptomic Modulators during Osteogenic Differentiation of Human Embryonic Stem Cells.
Yin J; Qi TF; Yang YY; Vera-Colón M; Zur Nieden NI; Wang Y
J Proteome Res; 2023 Jul; 22(7):2179-2185. PubMed ID: 37348120
[TBL] [Abstract][Full Text] [Related]
7. Targeted Profiling of Heat Shock Proteome in Radioresistant Breast Cancer Cells.
Miao W; Fan M; Huang M; Li JJ; Wang Y
Chem Res Toxicol; 2019 Feb; 32(2):326-332. PubMed ID: 30596229
[TBL] [Abstract][Full Text] [Related]
8. Profiling global kinome signatures of the radioresistant MCF-7/C6 breast cancer cells using MRM-based targeted proteomics.
Guo L; Xiao Y; Fan M; Li JJ; Wang Y
J Proteome Res; 2015 Jan; 14(1):193-201. PubMed ID: 25341124
[TBL] [Abstract][Full Text] [Related]
9. Targeted Proteomic Analysis of Small GTPases in Radioresistant Breast Cancer Cells.
Gao Z; Yang YY; Huang M; Qi TF; Wang H; Wang Y
Anal Chem; 2022 Nov; 94(43):14925-14930. PubMed ID: 36264766
[TBL] [Abstract][Full Text] [Related]
10. Roles of Small GTPases in Acquired Tamoxifen Resistance in MCF-7 Cells Revealed by Targeted, Quantitative Proteomic Analysis.
Huang M; Wang Y
Anal Chem; 2018 Dec; 90(24):14551-14560. PubMed ID: 30431262
[TBL] [Abstract][Full Text] [Related]
11. Targeted m
Rauch S; Dickinson BC
Methods Enzymol; 2019; 621():1-16. PubMed ID: 31128773
[TBL] [Abstract][Full Text] [Related]
12. Development and characterisation of acquired radioresistant breast cancer cell lines.
Gray M; Turnbull AK; Ward C; Meehan J; Martínez-Pérez C; Bonello M; Pang LY; Langdon SP; Kunkler IH; Murray A; Argyle D
Radiat Oncol; 2019 Apr; 14(1):64. PubMed ID: 30987655
[TBL] [Abstract][Full Text] [Related]
13. LC-MS/MS-based targeted proteomics quantitatively detects the interaction between p53 and MDM2 in breast cancer.
Zhang W; Zhong T; Chen Y
J Proteomics; 2017 Jan; 152():172-180. PubMed ID: 27826076
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the Tyrosine Kinase-Regulated Proteome in Breast Cancer by Combined use of RNA interference (RNAi) and Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) Quantitative Proteomics.
Stebbing J; Zhang H; Xu Y; Grothey A; Ajuh P; Angelopoulos N; Giamas G
Mol Cell Proteomics; 2015 Sep; 14(9):2479-92. PubMed ID: 26089344
[TBL] [Abstract][Full Text] [Related]
15. Use of universal stable isotope labeling by amino acids in cell culture (SILAC)-based selected reaction monitoring (SRM) approach for verification of breast cancer-related protein markers.
Liu NQ; Dekker LJ; Van Duijn MM; Umar A
Methods Mol Biol; 2014; 1156():307-22. PubMed ID: 24791998
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of exosome-like vesicles from breast cancer cells.
Kruger S; Abd Elmageed ZY; Hawke DH; Wörner PM; Jansen DA; Abdel-Mageed AB; Alt EU; Izadpanah R
BMC Cancer; 2014 Jan; 14():44. PubMed ID: 24468161
[TBL] [Abstract][Full Text] [Related]
17. A merged method for targeted analysis of amino acids and derivatives using parallel reaction monitoring combined with untargeted profiling by HILIC-Q-Orbitrap HRMS.
Zhang L; Zheng W; Li X; Wang S; Xiao M; Xiao R; Zhang D; Ke N; Cai H; Cheng J; Chen X; Gong M
J Pharm Biomed Anal; 2021 Sep; 203():114208. PubMed ID: 34148019
[TBL] [Abstract][Full Text] [Related]
18. Large-Scale Analysis of Breast Cancer-Related Conformational Changes in Proteins Using SILAC-SPROX.
Liu F; Meng H; Fitzgerald MC
J Proteome Res; 2017 Sep; 16(9):3277-3286. PubMed ID: 28673085
[TBL] [Abstract][Full Text] [Related]
19. Proteomics Profiling of KAIMRC1 in Comparison to MDA-MB231 and MCF-7.
Alghanem B; Ali R; Nehdi A; Al Zahrani H; Altolayyan A; Shaibah H; Baz O; Alhallaj A; Moresco JJ; Diedrich JK; Yates JR; Boudjelal M
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570693
[TBL] [Abstract][Full Text] [Related]
20. SILAC-based proteomic profiling of the human MDA-MB-231 metastatic breast cancer cell line in response to the two antitumoral lactoferrin isoforms: the secreted lactoferrin and the intracellular delta-lactoferrin.
Hoedt E; Chaoui K; Huvent I; Mariller C; Monsarrat B; Burlet-Schiltz O; Pierce A
PLoS One; 2014; 9(8):e104563. PubMed ID: 25116916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
